Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02791880 · ClinicalTrials.gov registry record
Acute Kidney Injury Genomics and Biomarkers in TAVR Study
A clinical trial of Stroke and Heart Failure, sponsored by University of Texas Southwestern Medical Center.
- Active
- Registry status
- 62
- Enrollment target
- 3
- Study locations
NCT02791880 is a study of Stroke and Heart Failure that is active but no longer recruiting, run by University of Texas Southwestern Medical Center. The registered enrollment target is 62 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 1 state.
The verdict
NCT02791880, a study of Stroke and Heart Failure, is active but no longer recruiting, sponsored by University of Texas Southwestern Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- 62 participants
- Enrollment target
- 3
- Study locations
Study Summary
In the last decade, transcatheter aortic valve replacement (TAVR) has become an increasingly utilized alternative procedure for replacing a stenotic aortic valve. This study collects clinical information, DNA, blood and urine samples (throughout procedural hospitalization) in order to investigate the incidence of acute kidney injury (AKI) in patients undergoing TAVR and to identify key clinical and procedural predictors of AKI. This study seeks to identify blood and urine biomarkers that can be used for early detection of AKI around the time of the procedure. The study seeks to assess for novel genetic variants associated with development of AKI after TAVR. Finally the study seeks to assess for novel genetic variants and biomarkers that are associated with adverse cardiovascular events after TAVR and to further explore how these events may inter-relate with acute kidney injury.
Conditions Studied
Interventions
- PROCEDURE Transcatheter Aortic Valve Replacement
Study Locations (3)
Texas
- Parkland Health & Hospital Systems - Dallas
- University of Texas Southwestern Medical Center - Dallas
- William J. Clements University Hospital - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2016-10-25 |
| Est. Completion | 2031-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02791880
The ClinicalTrials.gov registry entry for NCT02791880 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Transcatheter Aortic Valve Replacement is the first listed.
NCT02791880 reports 3 study locations spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT02791880 about?
NCT02791880 is a clinical study titled "Acute Kidney Injury Genomics and Biomarkers in TAVR Study". In the last decade, transcatheter aortic valve replacement (TAVR) has become an increasingly utilized alternative procedure for replacing a stenotic aortic valve. This study collects clinical information, DNA, blood and urine samples (throughout procedural hospitalization) in order to investigate th...
What is the current status of trial NCT02791880?
This trial is currently active not recruiting. The enrollment target is 62 participants. The study started on 2016-10-25. Estimated completion is 2031-03-31.
What conditions does trial NCT02791880 study?
This clinical trial studies the following conditions: Stroke, Heart Failure, Acute Kidney Injury, Myocardial Infarction, Arrhythmias, Cardiac.
What interventions are being tested in trial NCT02791880?
The interventions under investigation include: Transcatheter Aortic Valve Replacement (PROCEDURE).
Who is sponsoring clinical trial NCT02791880?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02791880 being conducted?
This trial has 3 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The SLEEPR Study: SLEep Effects on Post-stroke Rehabilitation
RECRUITING
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Genetic and Environmental Risk Factors for Hemorrhagic Stroke
RECRUITING
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.